Top 4 Stocks About to Reach Their 52-Week High
A 52-week high is a technical indicator used by some of the world's top traders and investors to determine the current and future value of a stock. In this report we reveal today's top 4 stocks about to reach their 52-week highs.
By clicking the link above you will automatically opt-in to receive emails from ActivaTrade
Shares Stats
Shares Outstanding | 3,152,780,032 |
Shares Float | 3,126,147,656 |
Shares Short | 6,566,171 |
Institution Holdings | 3.50% |
About Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rare diseases, such as rare metabolic and hematology, and heredity angioedema, as well as plasma-derived therapies and vaccines. The company provides its products under the ENTYVIO, GATTEX/REVESTIVE, ALOFISEL, NATPARA, ADYNOVATE/ADYNOVI, TAKHZYRO, ELAPRASE, VPRIV, GAMMAGARD LIQUID/KIOVIG, HYQVIA, CUVITRU, ALBUMIN/FLEXBUMIN, NINLARO, and ALUNBRIG brands. It operates in Japan, the United States, Europe and Canada, Russia/CIS, Latin America, rest of Asia, the Middle East, Oceania, and Africa. The company has licensing agreements with TESARO, Inc., Denali Therapeutics, and Wave Life Sciences Ltd; collaboration agreements with Rani Therapeutics LLC, Novimmune S.A., AB Biosciences Inc., Sosei Group Corporation, and LogicBio Therapeutics, Inc.; strategic collaboration with Prometheus Biosciences, Inc; a license and research agreement with The University of Texas MD Anderson Cancer Center; a research collaboration agreements with Enzyre BV and Cerevance; a collaboration agreement with Artisan Bio, Inc.; and a multi-target rare disease collaboration with Evox Therapeutics Ltd., as well as licensing agreement with ProThera Biologics Inc. It also has a corporate strategic research alliance with Egle Therapeutics SAS; a strategic partnership with Neurocrine Biosciences, Inc.; Carmine Therapeutics and HemoShear Therapeutics, LLC; and strategic collaboration with KSQ Therapeutics to research, develop, and commercialize immune-based therapies for cancer. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.
General
Name | Takeda Pharmaceutical Company Limited |
Ticker | TAK |
Exchange | NYSE |
Sector | Healthcare |
Industry | Drug Manufacturers-Specialty & Generic |
Currency | USD |
Country | USA |
Fiscal Year End | March |
Full Time Employees | 47,495 |
Highlights
Analyst Target | 22.79 |
Market Cap | 61,566,029,824 |
PE Ratio | 31.48 |
PEG Ratio | 0.14 |
Financials
Curr Year EPS Estimate | 0.85 |
Profit Margin | 0.06 |
Return on Assets | 0.01 |
Return on Equity | 0.04 |
Earnings Per Share | 0.81 |
Gross Profit | 2,201,453,000,000 |
Quarterly Revenue Growth | -0.03 |
Valuation
Trailing PE | 23.78 |
Forward PE | 10.55 |
Price/Sales (Trailing 12 Mt.) | 2.10 |
Price/Book (Most Recent Quarter) | 1.45 |
Dividend
Takeda Pharmaceutical Company Limited pays out a dividend of $1.64 per share, with a dividend yield of 2.41%.
TAK's last dividend payment was made to shareholders on December 15, 2009.
They pay out 38.98% of their earnings out as a dividend.
Recent Dividends
Dec 11, 2023 | $0.32 |
Jul 10, 2023 | $0.31 |
Dec 12, 2022 | $0.33 |
Jul 11, 2022 | $0.33 |
Dec 13, 2021 | $0.40 |
Jul 12, 2021 | $0.41 |
Dec 11, 2020 | $0.43 |
Jul 6, 2020 | $0.42 |
AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst
Cantor Fitzgerald initiates coverage on AbbVie with an Overweight rating and a $200 price target. AbbVie is set to manage Humira biosimilar erosion, drive growth with Skyrizi, Rinvoq, and emraclidine, and achieve a high single-digit CAGR from 2024 to 2029.
Trump Vs. Biden: 2024 Election Poll Shows Tie Broken -- Which Candidate Gains Support From His Party, Independent Voters?
A new 2024 election poll shows a close race between Donald Trump and Joe Biden. One candidate gained ground with their party and Independent voters.
Could Elon Musk's New Device Save Us from A.I. Apocalypse? - Ad
A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. So he invented this strange new device to protect us against that A.I. threat. See this strange device you could be wearing some day.
After Elon Musk, Argentina's President Milei To Meet Mark Zuckerberg And Other Tech Leaders In Silicon Valley: Report
Argentine President Javier Milei is planning to meet top tech executives in Silicon Valley, including Mark Zuckerberg, OpenAI and others.
GameStop, AMC, Plug Power, Rumble, Tesla: Why These 5 Stocks Are Investors' Radars Today
major U.S. stock indices closed higher, with the Dow Jones Industrial Average increasing by 0.3% to 39,558.11.
Discover "U.S.'s New Money" Before Biden Wins - Ad
A new form of money has emerged in America, and it's making some folks wildly rich... (Musk and Bezos both use it). Find out how you can too in this free video.
Amid Nvidia Craze, Jim Cramer Sees A Chip Stock 'Not On Anyone's Radar' About To Break Out: Here's What He Said
Despite it not being on anyone's radar, Jim Cramer believes that Broadcom is about to break out.
Marjorie Taylor Greene Accused Of Racist Behavior By Jasmine Crockett Over 'Fake Eyelashes' Comment
Crockett accuses Greene of racism over fake eyelashes taunt during a hearing. Crockett says Greene has not attacked other colleagues' appearances.
Mystery of the Rich and Connected Revealed - Ad
Former Goldman VP reveals a mysterious "Gold Bank" with huge upside potential... Last time we shared this, some folks could have seen a 995% gain. Don't be surprised if you've never heard of this -- most haven't. But he's sharing all in this new video.
REE Automotive: Electrifying The Truck Stop? Analyst Bullish On EV Platform
Analyst initiates Buy rating for REE Automotive with $14 price target. Expects growth catalyst in FY24, revenue ramp in FY25, positive margins in FY26.
Amid 'Mass Exodus' From OpenAI's AI Safety Team, Insider Says 'Trust Collapsing Bit By Bit' In CEO Sam Altman: Report
OpenAI's AI Safety team is facing a "mass exodus" after resignations of leaders of the superalignment team, Ilya Sutskever and Jan Leike.
Buy This Next Gen Crypto Before Its Big Upgrade - Ad
Experts predict this one crypto will soar 7,200% by the end of the decade... and grow 20X bigger than bitcoin. But you must get in before it's big.
Ryan Cohen's Wealth Soars On GameStop Stock Rally: How Much Is Video Game Retailer CEO Worth?
The wealth of GameStop CEO Ryan Cohen has surged thanks to a rise in the share price.
Red Lobster closes dozens of locations across the US just months after 'endless shrimp' losses
NEW YORK (AP) — Dozens of Red Lobster locations across the U.S. are on the chopping block.
Amazon's Betting Big on This Unknown AI Company - Ad
Amazon has just made a stunning $144 million investment in one small AI company. Why? Because this under-the-radar firm holds the key to unleashing the full potential of next-gen AI... Its technology is crucial for the most advanced AI chips, including Nvidia's latest breakthrough.
US prisoners are being assigned dangerous jobs. But what happens if they are hurt or killed?
PHOENIX (AP) — Blas Sanchez was nearing the end of a 20-year stretch in an Arizona prison when he was leased out to work at Hickman’s Family Farms, which sells eggs that end up in the supply chains of huge companies like McDonald’s, Target and Albertsons. While assigned to a machine that churns chicken droppings into compost, his right leg got pulled into a chute with a large spiraling augur.
Breakthrough For Tesla In China? Shanghai Reportedly Greenlights 'Ordinary' Data Flow Overseas For Intelligent Vehicles
Tesla is also making plans for a data center in China to train its full self-driving (FSD) driver assistance software on fleet data from the country, Reuters reported.
Shhh! This Is One Great Coin... - Ad
Shhh! I truly believe this crypto could be one of the top earning cryptos of all time... In fact, in the coming bull run... this one coin could have the potential to bank 10x... 50x... and even 100x.
Buffett Says No Other Americans Would Have Had To Pay Even A Dime In Federal Taxes If This Had Happened
Warren Buffett suggests that federal taxes will likely increase given the country's precarious fiscal position, and he expressed Berkshire's willingness to cover the tax bill it faces.
Instacart partners with Uber Eats to offer restaurant deliveries
Grocery delivery company is partnering with Uber Eats to offer a new perk to its customers: .
AI & Crypto in One $11 Investment - Ad
Right now, you can harness the power of two bull markets... Artificial intelligence and cryptos...In one simple $11 investment.
Bitcoin, Ethereum, Dogecoin See Long-Sought Relief Rally On Favorable Inflation Data Numbers: Analyst Forecasts $68K-$69K As Next Test For King Crypto
The cryptocurrency market ushered in a strong rally Wednesday, following lower-than-expected retail inflation data.
In Cannes, Francis Ford Coppola talks Trump, self-financing 'Megalopolis' and why he has no regrets
CANNES, France (AP) — Much attention has been paid to the $120 million of his own fortune that put up to make but the director himself isn't much concerned.
Gold Is SOARING -- Here's What You Need to Do - Ad
Everything is lining up perfectly for a historic gold bull run. One gold expert says he's found the best way to get in, for less than $5.
Cathie Wood's Ark Invest Snaps Up $3.54M Worth Of Shares In This Biopharma Company Following Positive Obesity Pipeline Update
As the demand for obesity drugs continues to surge, biopharma companies are eagerly seizing the opportunity to capitalize on the trend.
Jim Cramer Advises Investors To Stick With Good Companies Despite Short-Term Losses: 'You Just Need To Figure Out Which Companies Deserve Your Confidence'
Cramer, a prominent figure in the finance world, suggested that investors should not emulate the trading habits of large hedge funds. Instead, he recommended a long-term investment strategy, emphasizing the need to anticipate and endure market declines.
$25 AI Stock Could Deliver Life-Changing Windfall - Ad
Discover a company at the forefront of the AI revolution, with up to $1 billion in government-backed contracts and 1,372 patent applications. Trading at just $25 a share...
Katy Perry and Rihanna didn't attend the Met Gala. But AI-generated images still fooled fans
NEW YORK (AP) — No, and didn't attend the this year. But that didn't stop AI-generated images from tricking some fans into thinking the stars made appearances on the steps of fashion's biggest night.
Bitcoin 'Could Still Have A Correction Down,' Cautions Lark Davis: 'Let's Not Get Ahead Of Ourselves'
In his latest podcast update, cryptocurrency trader Lark Davis previewed what could lay ahead for Bitcoin (CRYPTO: BTC) and different altcoins
Could Elon's New Device be Bigger than the iPhone? - Ad
According to 30-year Silicon Valley and Wall Street veteran, Eric Fry... A man who picked 41 plays that jumped 1,000%+... This mind-blowing new technology could be bigger than the iPhone. And it could make a lot of people wealthy in the coming months and years.
Stock market today: Asian shares are mixed as China stocks get bump from new property measures
Asian shares were mixed on Friday, with Chinese stocks reversing earlier losses following the announcement of to revive the ailing property market.
Google Seeks To Repeat Chromebook Success In Education By Rolling Out 'Gemini' AI For Schools, Promises Enhanced Data Privacy
Google is set to introduce its Gemini AI to schools with enhanced data privacy protections, ensuring that educational data is not used for AI training or shared with third parties.
"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." - Ad
The former Goldman Sachs VP -- who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio -- is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio."
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA).
Theft of more than 400 vehicles in Michigan leads to the arrest of 6 men
LANSING, Mich. (AP) — Six men working as part of a criminal organization in Michigan have been arrested in connection with the theft of more than 400 vehicles worth about $8 million, authorities said Thursday.
Crypto Millionaires Names His Favorite AI Coin - Ad
According to Bitcoin pioneer and crypto millionaire Charlie Shrem, a tiny $11 project could be the biggest winner of not just the next year, but the next decade. It combines AI and crypto, in one investment.
Federal Judge Indefinitely Postpones Donald Trump's Classified Documents Trial
The trial of ex-President Donald Trump for retaining classified documents has been postponed indefinitely by a federal judge.
Stock Market Rally For 2024 Has Peaked, Goldman Sachs Forecasts 'Flat Return From Now Till The End Of The Year'
The stock market rally for 2024 has reached its peak, according to Goldman Sachs. The firm's chief U.S. equity strategist, David Kostin, has predicted a flat return for the S&P 500 for the remainder of the year.
The Mysterious Tale of "America's No. 1 Retirement Stock" - Ad
This factory of 53,000 employees, in Burbank, CA, was camouflaged to look like a sleepy suburb (with the help of artists, set designers, and painters from nearby Hollywood movie studios). The mysterious company behind this disappearing act is now being called "America's No. 1 Retirement Stock".
I-95 overpass in Connecticut scorched during a fuel truck inferno has been demolished
NORWALK, Conn. (AP) — A bridge damaged in a fiery crash that kept Interstate 95 in Connecticut has been demolished.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.